West Pharmaceutical Services, Inc. (NYSE:WST) Shares Acquired by Vest Financial LLC

Vest Financial LLC raised its position in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 31.0% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 151,217 shares of the medical instruments supplier's stock after buying an additional 35,771 shares during the quarter. Vest Financial LLC owned about 0.21% of West Pharmaceutical Services worth $45,389,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of WST. Fidelis Capital Partners LLC acquired a new stake in shares of West Pharmaceutical Services in the 1st quarter valued at approximately $27,000. Crewe Advisors LLC lifted its holdings in West Pharmaceutical Services by 322.7% in the second quarter. Crewe Advisors LLC now owns 93 shares of the medical instruments supplier's stock valued at $31,000 after acquiring an additional 71 shares during the period. Northwest Investment Counselors LLC purchased a new stake in shares of West Pharmaceutical Services during the 1st quarter worth $40,000. Hazlett Burt & Watson Inc. acquired a new position in shares of West Pharmaceutical Services during the 1st quarter worth $40,000. Finally, ORG Partners LLC grew its stake in shares of West Pharmaceutical Services by 820.0% during the 1st quarter. ORG Partners LLC now owns 138 shares of the medical instruments supplier's stock worth $55,000 after purchasing an additional 123 shares during the period. Hedge funds and other institutional investors own 93.90% of the company's stock.

West Pharmaceutical Services Price Performance

Shares of NYSE WST traded up $4.66 during midday trading on Friday, hitting $293.32. The company had a trading volume of 640,174 shares, compared to its average volume of 594,825. The firm has a market capitalization of $21.28 billion, a price-to-earnings ratio of 41.72, a price-to-earnings-growth ratio of 10.46 and a beta of 1.01. West Pharmaceutical Services, Inc. has a twelve month low of $265.00 and a twelve month high of $413.70. The business has a 50-day simple moving average of $299.96 and a two-hundred day simple moving average of $324.95. The company has a quick ratio of 1.68, a current ratio of 2.34 and a debt-to-equity ratio of 0.03.

West Pharmaceutical Services (NYSE:WST - Get Free Report) last posted its quarterly earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.74 by ($0.22). The company had revenue of $702.10 million for the quarter, compared to analyst estimates of $729.36 million. West Pharmaceutical Services had a net margin of 18.25% and a return on equity of 19.17%. West Pharmaceutical Services's revenue was down 6.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.11 earnings per share. Equities research analysts anticipate that West Pharmaceutical Services, Inc. will post 6.42 earnings per share for the current year.

Insiders Place Their Bets

In other news, VP Charles Witherspoon sold 1,029 shares of West Pharmaceutical Services stock in a transaction on Monday, August 19th. The stock was sold at an average price of $300.00, for a total transaction of $308,700.00. Following the completion of the transaction, the vice president now owns 1,478 shares of the company's stock, valued at $443,400. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 0.53% of the stock is owned by company insiders.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.